Approval · Notice of Compliance 8869 · 2007
CIALIS: Notice of Compliance 8869
Issued June 27, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8869
- Date
- June 27, 2007
- Company
- Lilly Icos Llc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths 2.5mg and 5mg tablets to be used as once a day
- Therapeutic class
- Cgmp-specific phosphodiesterase type 5 inhibitor